Unspecific elevation of plasma troponin-T and CK-MB after coronary surgery
L-G Dahlin1, B Kågedal, E Nylander
1Department of Cardiothoracic Surgery, University Hospital, Linköping, Sweden. Lars-Goran.Dahlin@lio.se
Insights
Cardiac surgery patients without permanent heart damage show significant early elevations in troponin-T and creatine kinase-MB (CK-MB). These unspecific marker releases occur during critical evaluation periods after coronary artery bypass grafting.
Area of Science:
- Cardiology
- Biochemistry
- Cardiac Surgery
Background:
- Elevated biochemical markers of myocardial injury are common post-cardiac surgery.
- A portion of these elevations is attributed to release unrelated to permanent myocardial damage.
- The characteristics of this 'diagnostic noise' are not well understood.
Purpose of the Study:
- To investigate the magnitude and temporal profile of biochemical marker release in cardiac surgery patients without permanent myocardial injury.
- To characterize the 'diagnostic noise' in troponin-T and creatine kinase-MB (CK-MB) levels post-coronary artery bypass grafting (CABG).
Main Methods:
- Utilized unique troponin-T release kinetics to identify patients with no or minimal permanent myocardial injury after CABG with cardiopulmonary bypass (CPB).
- Blood samples were collected pre-surgery and at multiple time points up to postoperative day 4.
- Identified a subgroup (n=77) with normalized troponin-T by day 4 and no ECG changes indicative of injury.
Main Results:
- In the selected subgroup, troponin-T peaked at 3 hours post-aortic unclamping (2.08 ± 1.42 µg/l).
- Creatine kinase-monobasic (CK-MB) peaked at 8 hours post-aortic unclamping (28.6 ± 11.3 µg/l).
- These substantial early elevations occurred despite no or minimal permanent myocardial injury.
Conclusions:
- Significant early elevations in plasma CK-MB and troponin-T are observed in CABG patients without permanent myocardial injury.
- This unspecific marker release is most pronounced during timeframes typically used to assess myocardial protection strategies or revascularization procedures.
- Findings highlight the need to consider non-specific marker release when interpreting results after cardiac surgery.
Objective:
Biochemical markers of myocardial injury are frequently elevated after cardiac surgery. It is generally accepted that release unrelated to permanent myocardial damage explains a proportion of these elevations. However, little is known about the magnitude and temporal characteristics of this diagnostic noise. One way to address this issue would be to study a group without permanent myocardial injury.
Design:
The unique release kinetics of troponin-T (permanent myocardial injury causes a sustained release of structurally bound troponin) were used to identify patients with no or minimal permanent myocardial injury. Blood was sampled from patients undergoing coronary artery bypass grafting (CABG) with cardiopulmonary bypass (CPB) before surgery, 3 and 8 h after unclamping the aorta, and each morning until postoperative day 4, for analysis of enzymes and troponin-T. From 302 consecutive patients a subgroup was identified that fulfilled the following criteria: (a) normalized troponin-T levels < or = postoperative day 4; (b) no ECG changes indicating myocardial injury.
Results:
Seventy-seven patients fulfilled the criteria above and in this subgroup troponin-T (2.08 +/- 1.42 microg/l; range 0.35-8.99 microg/l) peaked at the 3 h recording and creatine kinase monobasic (CK-MB) (28.6 +/- 11.3 microg/l; range 11.9-86.0 microg/l) peaked at the 8 h recording after unclamping the aorta.
Conclusion:
Substantial early elevations of plasma CK-MB and troponin-T occurred in patients with no or minimal permanent myocardial injury after CABG. Unspecific release was most pronounced during the timeframe that is usually studied to evaluate myocardial protective strategies or to compare revascularization procedures.
More Related Videos
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Imaging Studies for Cardiovascular System V: CT
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
